Related Experiment Video
Updated: Jul 22, 2026
Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury
Published on: November 19, 2012
Optimizing and simplifying post-traumatic amnesia testing after moderate-severe traumatic brain injury despite common
M J Hennessy1, L A G Marshman2, L Delle Baite3
1Dept Psychology, Charles Darwin University, Darwin, Northern Territory 0810, Australia; Dept Psychology, James Cook University Singapore, Singapore 387380, Singapore.
This study found that combining specific items from the Westmead Post-traumatic Amnesia Scale (WPTAS) and Galveston Orientation and Amnesia Test (GOAT) improved the accuracy of diagnosing post-traumatic amnesia (PTA) after traumatic brain injury (TBI). This optimized testing approach accounts for clinical confounders like opioid use.
Area of Science:
- Neuroscience
- Clinical Psychology
- Trauma Care
Background:
- Post-traumatic amnesia (PTA) duration is crucial for diagnosing traumatic brain injury (TBI) and predicting outcomes.
- Existing PTA assessment tools exhibit variability, potentially over- or under-estimating PTA duration.
- The impact of in-hospital factors, such as opioid administration, on PTA assessment is not well understood.
Purpose of the Study:
- To evaluate the diagnostic accuracy of the Westmead Post-traumatic Amnesia Scale (WPTAS) and the Galveston Orientation and Amnesia Test (GOAT) in patients with moderate-severe TBI (MS-TBI).
- To investigate the influence of clinical confounders, including opioids, on PTA assessment.
- To develop an optimized PTA testing protocol by combining elements from WPTAS and GOAT.
Main Methods:
- Prospective recruitment of three groups: in-patients with MS-TBI (Group 1), patients recovering from MS-TBI (Group 2), and orthopedic patients without TBI (Group 3).
- Administration of WPTAS and GOAT to all participants.
- Analysis of WPTAS and GOAT scores, sensitivity, specificity, and predictive values for distinguishing between groups, considering opioid use.
Main Results:
- WPTAS scores were similar between MS-TBI patients (Group 1) and orthopedic patients (Group 3), but lower than in recovering MS-TBI patients (Group 2).
- GOAT scores were significantly lower in Group 1 compared to Groups 2 and 3, with no patient scoring below 75.
- A combined WPTAS and GOAT approach, using specific items, achieved high sensitivity (100%) and specificity (85-88%) in differentiating MS-TBI patients.
Conclusions:
- Opioids and other in-hospital factors likely influenced WPTAS performance but not GOAT specificity.
- A merged PTA testing strategy, leveraging the strengths of both WPTAS and GOAT, enhances diagnostic accuracy.
- A simplified, combined PTA assessment using fewer items offers a more effective and practical approach for patients and clinicians.
